Archives
2008
September 15, 2008
FDA Grants Approval to Talecris Biotherapeutics for Gamunex® as a Treatment for Neurological Disorder CIDP in the United States
August 29, 2008
Ampersand Ventures leads recapitalization of MedVenture Technology Corporation
August 21, 2008
Signature Genomic Laboratories Named to Inc. 5000
August 12, 2008
Talecris Enters into Definitive Merger Agreement with CSL
July 17, 2008
ChanTest to Highlight the World’s Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Drug Discovery Technology, Booth 839
July 1, 2008
IBT Laboratories Names Maureen Loftus President and Chief Operating Officer
June 24, 2008
Signature Reports Investment in Company and Appointment of New Chairman of Board of Directors
June 16, 2008
Talecris Biotherapeutics, Inc. Provides Business Update
May 29, 2008
Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
May 15, 2008
Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays
May 08, 2008
FDA Grants Priority Review of Gamunex® as a Treatment for Neurological Disorder CIDP
April 29, 2008
Endeca Named One of Massachusetts’s Fastest Growing Private Company in Boston Business Journal Annual Ranking
March 26, 2008
Significant award further enhances MEDIFACTS’ position as one of the top cardiac safety services providers
January 23, 2008
Endeca Receives Investment from SAP Ventures
January 23, 2008
Intel Capital Invests $10 Million in Endeca
January 10, 2008
Signature microarray covers regions of the genome associated with autism
January 5, 2008
Ampersand Ventures Announces Acquisition of K-TEK Corporation, a Leading Supplier of Level Measurement Instrumentation to the Process Industries
2007
November 28, 2007
RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital
October 3, 2007
CRI Worldwide Partners with Private Equity Investors to Advance Growth Strategy
August 28, 2007
Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
August 6, 2007
ChanTest Receives Expansion Capital from Ampersand Ventures; Builds World’s Largest Catalog of Ion Channel-Expressing Cell Lines for Use in Drug Discovery and Development
June 18, 2007
Cequent Pharmaceuticals Completes $9 Million Series a Financing With Equity Investment from Novartis Option Fund
May 31, 2007
Endeca Reports Record Q1 Revenue, Plans to Create Hundreds of New Jobs
April 2, 2007
Ortho Organizers, Inc. Introduces New Product Line - Ancor Pro Orthodontic Anchorage System
March 20, 2007
Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs
January 4, 2007
Victory Pharma, Inc. Signs NAPRELAN® Agreement; US Field Sales Force to Expand
January 3, 2007
Victory Pharma, Inc. Announces Investigational New Drug MGX-006 Approved by the FDA
2006
November 28, 2006
Magellan Biosciences Expands Presence in Hospital-Based Laboratory Market with Acquisition of TREK Diagnostic Systems
November 20, 2006
Talecris Biotherapeutics Completes Acquisition of Plasma Collection Centers
2005
August 5, 2005
Ortho Organizers, Inc. Announces Change in Ownership
July 11, 2005
Assay Designs Acquires Stressgen Bioreagents
May 9, 2005
Ampersand Invests in Assay Designs
April 1, 2005
Announcing the Launch of Talecris Biotherapeutics: Combining a Proud History of Patient Care with a Bold New Vision
2004
December 13, 2004
Bayer To Divest its Plasma Products Business To US Investors Cerberus and Ampersand
December 1, 2004
Ampersand Ventures Invests in IBT Reference Laboratory
October 19, 2004
Magellan Biosciences, Inc. Formed Through Combination of ESA and Dynex
May 20, 2004
Ampersand Ventures Acquires Life Science Tools Provider ESA, Inc.